🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase III, multicenter, open-label, randomized controlled trial. ...
Status
Recruiting
Location
Henan Cancer Hospital
Start Date
2026-06-16
Trial ID
NCT07629817
This study aims to systematically evaluate the safety and efficacy of adali...
Status
Recruiting
Location
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Start Date
2026-05-22
Trial ID
NCT07595770
Treatments Being Tested
This multicentre, randomized controlled trial evaluates the effect and safe...
Status
Recruiting
Location
Guangdong Provincial Hospital of Chinese Medicine
Start Date
2026-01-15
Trial ID
NCT07337096
Treatments Being Tested
Aumolertinib is a third-generation epidermal growth factor receptor (EGFR) ...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2022-12-14
Trial ID
NCT05493501
This is a phase II study to assess the efficacy, safety, and Health Related...
Status
Recruiting
Location
Ryan Nguyen
Start Date
2022-12-28
Trial ID
NCT05613413
Treatments Being Tested
The purpose of this study is to evaluate sacituzumab tirumotecan versus pem...
Status
Active Not Recruiting
Location
Kaiser Permanente - Oakland ( Site 0054)
Start Date
2024-06-11
Trial ID
NCT06305754
This study aims to evaluate the efficacy and safety of induction Adebrelima...
Status
Not Yet Recruiting
Location
The Fourth Hospital of Hebei Medical University
Start Date
2025-08-10
Trial ID
NCT07112833
RATIONALE: Drugs used in chemotherapy, such as paclitaxel albumin-stabilize...
Status
Completed
Location
Baylor Research Institute
Start Date
2009-03-01
Trial ID
NCT00851877
Treatments Being Tested
Neoadjuvant Short-Course Radiotherapy Followed by Tislelizumab Plus Chemoth...
Status
Not Yet Recruiting
Location
Tangdu Hospital, Fourth Military Medical University
Start Date
2026-07-10
Trial ID
NCT07678580
This study is a prospective, single-arm, phase II exploratory clinical tria...
Status
Recruiting
Location
The Second Qilu Hospital of Shandong University
Start Date
2024-12-09
Trial ID
NCT07430579
Treatments Being Tested